3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
3
Advanced Breast Cancer
2
ER+ HER2- Advanced Breast Cancer
1
Interventions
ribociclib
1
palbociclib
1
abemaciclib
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
ER+ HER2- Advanced Breast Cancer
×
AZD9833
×
Clear all
NCT06188520
2026-05-11
CYCAD-1
AstraZeneca
Phase 1/2
Recruiting
564 enrolled